No definition available.
Congenital malformations of the respiratory system
EFO MESH Endpoint Browser PheWeb
Q17_CONGEN_MALFO_RESPI_SYSTEM
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters: 2 out of 7 registries used, show all original rules. |
606 |
4. Check minimum number of eventsNone |
606 |
5. Include endpoints |
606 |
6. Filter based on genotype QC (FinnGen only) |
606 |
Control definitions (FinnGen only)
Controls for this endpoint are individuals that are not cases.
Extra metadata
- Level in the ICD hierarchy
- 2
- First used in FinnGen datafreeze
- DF4
- Parent code in ICD-10
- Q
- Name in latin
- Malformationes congenitae systematis respiratorii
Similar endpoints
↥List of similar endpoints to
Congenital malformations of the respiratory system
based on the number of shared cases.
Similar with more cases:
- Congenital malformations, deformations and chromosomal abnormalities
- Any event in hilmo or specialist outpatient
Similar with less cases:
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 7047 | 3406 | 3623 |
| Only index persons | 4802 | 2461 | 2341 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.10 | 0.10 | 0.10 |
| Only index persons | 0.09 | 0.09 | 0.09 |
| Median age at first event (years) | |||
| Whole population | 10.90 | 21.32 | 0.82 |
| Only index persons | 30.26 | 46.96 | 12.69 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 606 | 360 | 246 |
| Unadjusted period prevalence (%) | 0.12 | 0.12 | 0.11 |
| Median age at first event (years) | 49.53 | 52.17 | 45.66 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 563
- Matched controls
- 5625
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
Q32.21
ICD-10 Finland
Secondary congenital bronchomalacia
+∞
161.4
147
*
UGC12
NOMESCO Finland
Flexible bronchoscopy
20.0
140.0
225
181
Q32.0
ICD-10 Finland
Congenital tracheomalacia
+∞
111.2
103
*
R03BB04
ATC
tiotropium bromide; inhalant
7.7
53.2
134
218
R03AC02
ATC
salbutamol; inhalant
4.1
51.7
414
2263
Q31.40
ICD-10 Finland
Congenital laryngomalasia
+∞
49.7
47
*
J45.9
ICD-10 Finland
Asthma, unspecified
4.8
48.9
198
574
J98.0
ICD-10 Finland
Diseases of bronchus, not elsewhere classified
83.3
41.5
46
6
R03AK06
ATC
salmeterol and fluticasone; inhalant
4.9
40.8
151
388
Q34.1
ICD-10 Finland
Congenital cyst of mediastinum
+∞
40.1
38
*
GD1AA
NOMESCO Finland
Thorax X-ray examination
3.3
39.0
314
1560
J18.9
ICD-10 Finland
Pneumonia, unspecified
3.8
37.8
196
689
R91
ICD-10 Finland
Abnormal findings on diagnostic imaging of lung
6.2
37.3
109
211
R03DC03
ATC
montelukast; oral
4.1
36.8
170
537
XG412
NOMESCO Finland
Flow-volume spirometry with bronchospasmolysis
6.5
36.8
103
188
J45.1
ICD-10 Finland
Nonallergic asthma
5.6
36.4
116
249
Q32.20
ICD-10 Finland
Congenital bronchomalacia
368.7
35.3
35
*
203
Kela drug reimbursment
Chronic asthma and similar chronic obstructive pulmonary diseases
3.7
35.2
185
650
R06.0
ICD-10 Finland
Dyspnoea
3.4
33.1
201
785
H02AB06
ATC
prednisolone; systemic
3.0
32.9
314
1677
UGC02
NOMESCO Finland
Rigid bronchoscopy
31.4
31.2
41
14
J47
ICD-10 Finland
Bronchiectasis
24.4
30.5
43
19
XG470
NOMESCO Finland
Measurement of diffusion capastity of the lungs
13.3
27.8
49
40
R05
ICD-10 Finland
Cough
3.2
27.5
177
704
R03BA08
ATC
ciclesonide; inhalant
5.0
26.6
92
213
R03BA05
ATC
fluticasone; inhalant
3.1
26.4
181
749
XG410
NOMESCO Finland
Flow-volume spirometry
6.8
26.1
68
111
J15.9
ICD-10 Finland
Bacterial pneumonia, unspecified
5.0
25.4
87
199
Q31.3
ICD-10 Finland
Laryngocele
+∞
25.2
24
*
R03BA02
ATC
budesonide; inhalant
3.2
24.2
147
554
Q33.2
ICD-10 Finland
Sequestration of lung
+∞
24.1
23
*
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
3.4
23.0
129
457
R03BB01
ATC
ipratropium bromide; inhalant
9.1
22.6
48
57
J20.9
ICD-10 Finland
Acute bronchitis, unspecified
3.1
22.5
143
555
J46
ICD-10 Finland
Status asthmaticus
8.0
22.2
51
69
Q30.8
ICD-10 Finland
Other congenital malformations of nose
+∞
22.0
21
*
R03DA04
ATC
theophylline; systemic, rectal
6.5
21.7
58
98
R96
ICPC
Asthma
4.2
21.6
87
233
G47.3
ICD-10 Finland
Sleep apnoea
3.0
21.2
146
594
GD1BD
NOMESCO Finland
Thorax extensive CT-examination
5.6
20.4
61
119
Z01.8
ICD-10 Finland
Other specified special examinations
2.8
20.2
160
709
DM1QA
NOMESCO Finland
Paranasal sinuses X-ray examination in one projection
5.9
20.1
58
108
R03AK07
ATC
formoterol and budesonide; inhalant
2.9
20.0
139
565
J01MA14
ATC
moxifloxacin; systemic
4.3
19.8
78
204
WX704
NOMESCO Finland
Intubation
4.6
19.2
70
170
UDH02
NOMESCO Finland
Rhinopharyngoscopy
4.5
18.1
66
160
R03AC03
ATC
terbutaline; inhalant
3.1
18.0
109
403
Q33.08
ICD-10 Finland
Congenital cystic lung
+∞
17.8
17
*
TPH04
NOMESCO Finland
Cathetrisation of vein
2.6
17.2
144
651
WX725
NOMESCO Finland
Noninvasive ventilation
6.0
17.2
48
86
J01FA06
ATC
roxithromycin; oral
2.2
17.1
233
1350
R03BC03
ATC
nedocromil; inhalant
4.3
16.8
65
167
Q32.10
ICD-10 Finland
Other congenital malformations of trachea
+∞
16.7
16
*
J45.8
ICD-10 Finland
Mixed asthma
6.4
16.5
44
74
R06.1
ICD-10 Finland
Stridor
41.4
16.4
20
5
UDQ12
NOMESCO Finland
Flexible laryngoscopy
4.7
16.3
56
128
C03CA01
ATC
furosemide; systemic
2.5
16.2
153
735
R03AL02
ATC
salbutamol and ipratropium bromide; inhalant
17.8
15.7
24
14
J01CR02
ATC
amoxicillin and beta-lactamase inhibitor; systemic
2.1
15.7
329
2270
WX408
NOMESCO Finland
General anesthesy, balanced
2.2
15.5
196
1084
GD1DD
NOMESCO Finland
High resolution CT examination of lungs
5.4
15.5
47
93
J01MA12
ATC
levofloxacin; systemic
2.8
15.5
110
448
R03AC12
ATC
salmeterol; inhalant
5.6
15.3
45
86
SPAT1263
SPAT
Sampling
2.1
15.2
255
1594
R02
ICPC
Shortness of breath/dyspnoea
3.1
15.2
93
342
J45.0
ICD-10 Finland
Predominantly allergic asthma
3.2
15.0
85
298
R03BA01
ATC
beclometasone; inhalant
2.9
14.9
97
374
R03AL01
ATC
fenoterol and ipratropium bromide; inhalant
7.4
14.8
35
50
R05
ICPC
Cough
2.3
14.7
164
852
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
2.2
13.9
170
916
SPAT1059
SPAT
Spirometry at the office
4.6
13.7
48
112
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
2.5
13.6
116
524
Q30.9
ICD-10 Finland
Congenital malformation of nose, unspecified
+∞
13.6
13
*
Q31.1
ICD-10 Finland
Congenital subglottic stenosis
+∞
13.6
13
*
R03AK04
ATC
salbutamol and sodium cromoglicate; inhalant
16.7
13.5
21
13
XG474
NOMESCO Finland
Exhalation nntrogen oxide
5.4
13.4
40
78
GD1CD
NOMESCO Finland
Thorax extensive CT-examination
14.2
13.3
22
16
J01FA10
ATC
azithromycin; systemic
2.0
13.1
354
2606
R03AK08
ATC
formoterol and beclometasone; inhalant
4.7
13.1
45
103
N03AX16
ATC
pregabalin; oral
2.3
13.0
138
692
FM1EE
NOMESCO Finland
Extensive structural and functional ultrasound examination of heart
2.3
12.8
135
677
TPH07
NOMESCO Finland
Cathetrisation of artery
2.8
12.7
84
326
Q33.6
ICD-10 Finland
Hypoplasia and dysplasia of lung
+∞
12.5
12
*
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
2.9
12.3
78
294
R03AL09
ATC
formoterol, glycopyrronium bromide and beclometasone; inhalant
9.0
12.1
25
29
R04.2
ICD-10 Finland
Haemoptysis
6.7
12.0
30
47
WX892
NOMESCO Finland
Monitored bed care
3.2
11.9
66
225
SPAT1256
SPAT
Intramuscular and subcutaneous injection
1.9
11.9
239
1558
GD1AD
NOMESCO Finland
Thorax CT examination
4.5
11.9
42
99
J06.9
ICD-10 Finland
Acute upper respiratory infection, unspecified
1.9
11.7
281
1951
J42
ICD-10 Finland
Unspecified chronic bronchitis
12.9
11.7
20
16
R01AD08
ATC
fluticasone; nasal
2.1
11.6
157
878
R03AK03
ATC
[D] fenoterol & other drugs for obstructive airway dis; inhalant
4.4
11.4
41
99
GD1ED
NOMESCO Finland
Extensive high resolution CT examination of lungs
5.9
11.0
30
53
R06.2
ICD-10 Finland
Wheezing
3.6
11.0
50
149
J44.8
ICD-10 Finland
Other specified chronic obstructive pulmonary disease
3.3
10.9
56
183
R01AD09
ATC
mometasone; nasal
1.8
10.7
245
1655
A02BC05
ATC
esomeprazole; systemic
1.9
10.7
212
1362
H02AB07
ATC
prednisone; oral
2.5
10.6
85
368
R2130
NOMESCO Finland
Counselling and guidance which enhance independent living
2.7
10.6
77
316
R03AK10
ATC
vilanterol and fluticasone furoate; inhalant
4.4
10.5
37
88
GBA32
NOMESCO Finland
Endoscopic dilatation of trachea
111.9
10.4
11
*
SPAT1058
SPAT
PEF monitoring instruction
3.1
10.4
59
206
Q32.4
ICD-10 Finland
Other congenital malformations of bronchus
+∞
10.4
10
*
Q30.0
ICD-10 Finland
Choanal atresia
+∞
10.4
10
*
J22
ICD-10 Finland
Unspecified acute lower respiratory infection
3.8
10.4
44
124
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
2.4
10.2
88
396
R03AK11
ATC
formoterol and fluticasone; inhalant
6.1
10.2
27
46
J01CA04
ATC
amoxicillin; systemic
2.0
10.2
468
3973
J44.0
ICD-10 Finland
Chronic obstructive pulmonary disease with acute lower respiratory infection
5.5
10.1
29
55
H02AB04
ATC
methylprednisolone; systemic
2.4
9.9
88
400
Y83
ICD-10 Finland
Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
3.2
9.9
51
168
UGB02
NOMESCO Finland
Tracheoscopy
26.5
9.8
13
5
SPAT1301
SPAT
No procedures
1.9
9.7
182
1138
SPAT1230
SPAT
Aid fitting and borrowing and monitoring of use
2.3
9.7
96
462
WX402
NOMESCO Finland
General anaesthesia
2.1
9.5
117
620
504
Kela drug reimbursment
Conditions requiring daily forced enteral nutrition
6.4
9.5
24
39
SPAT1028
SPAT
Ultrasound examination of paranasal sinuses
3.7
9.5
41
118
Z93.0
ICD-10 Finland
Tracheostomy status
+∞
9.4
9
*
Q32.11
ICD-10 Finland
Congenital tracheo-esophageal fissure
+∞
9.4
9
*
R99
ICPC
Respiratory disease other
7.1
9.4
22
32
DLD00
NOMESCO Finland
Reconstruction of cartilage of nose
22.1
9.4
13
6
J45
ICD-10 Finland
Asthma
2.6
9.3
69
286
FB1BD
NOMESCO Finland
Extensive CT examination of arteria pulmonalis
3.1
9.3
52
180
AA1AD
NOMESCO Finland
CT of head and brain
2.0
9.1
122
669
J32.0
ICD-10 Finland
Chronic maxillary sinusitis
3.0
9.1
53
190
R50.9
ICD-10 Finland
Fever, unspecified
2.2
9.1
103
528
R06.5
ICD-10 Finland
Mouth breathing
2.6
9.0
67
278
R01AD58
ATC
fluticasone, combinations; inhalant, nasal
2.1
9.0
119
650
J01.0
ICD-10 Finland
Acute maxillary sinusitis
2.0
8.9
121
668
C01DA02
ATC
glyceryl trinitrate; oral, oral aerosol, sublingual, transdermal
2.3
8.9
91
443
J01AA02
ATC
doxycycline; systemic
1.8
8.9
382
3069
5191A
ICD-9 Finland
Other diseases of respiratory system, Other diseases of trachea and bronchus, not elsewhere classified
50.7
8.7
10
*
N06AX11
ATC
mirtazapine; oral
1.8
8.5
163
1020
Z03.9
ICD-10 Finland
Observation for suspected disease or condition, unspecified
2.1
8.5
109
589
Z50.9
ICD-10 Finland
Care involving use of rehabilitation procedure, unspecified
4.2
8.5
31
77
I50.9
ICD-10 Finland
Heart failure, unspecified
2.5
8.5
66
280
GCA18
NOMESCO Finland
Bronchoscopic dilatation of bronchus
91.3
8.4
9
*
J38.6
ICD-10 Finland
Stenosis of larynx
91.3
8.4
9
*
Q33.9
ICD-10 Finland
Congenital malformation of lung, unspecified
+∞
8.3
8
*
Q33.00
ICD-10 Finland
Solitary congenital cyst in the lungs
+∞
8.3
8
*
A02BC02
ATC
pantoprazole; systemic
1.7
8.3
313
2396
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
1.8
8.3
192
1272
XG405
NOMESCO Finland
Education on PEF monitoring
7.7
8.2
18
24
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
1.7
8.1
228
1603
F82
ICD-10 Finland
Specific developmental disorder of motor function
7.0
8.1
19
28
J01FA09
ATC
clarithromycin; systemic
1.8
8.1
178
1162
R03AC13
ATC
formoterol; inhalant
3.5
8.1
37
112
DLD20
NOMESCO Finland
Rhinoplasty
33.8
8.1
10
*
J96.1
ICD-10 Finland
Chronic respiratory failure
6.0
8.0
21
36
Z01.0
ICD-10 Finland
Examination of eyes and vision
2.0
8.0
107
584
WX404
NOMESCO Finland
Intravenous generell anesthesy
1.9
8.0
139
838
R09
ICPC
Sinus symptom/complaint
2.8
8.0
50
187
ZXA00
NOMESCO Finland
Right side
1.9
8.0
142
865
J01DB01
ATC
cefalexin; oral
1.8
8.0
426
3592
J44.1
ICD-10 Finland
Chronic obstructive pulmonary disease with acute exacerbation, unspecified
5.5
7.9
22
41
UDC00
NOMESCO Finland
Ear microscopy
2.6
7.8
56
227
A02BA02
ATC
ranitidine; systemic
2.0
7.8
100
538
UDQ02
NOMESCO Finland
Direct laryngoscopy
7.6
7.7
17
23
Q21.00
ICD-10 Finland
Multiple ventricular septal defect
18.6
7.6
11
6
A01AB04
ATC
amphotericin B; local oral
3.7
7.6
32
91
XG466
NOMESCO Finland
Sleep oxymetry
4.8
7.6
24
52
R28
ICPC
Limited function/disability (R)
10.2
7.6
14
14
DM1AA
NOMESCO Finland
Paranasal sinuses X-ray examination without contrast
4.0
7.6
29
76
N06AA09
ATC
amitriptyline; systemic
2.5
7.5
58
246
TGC00
NOMESCO Finland
Bronchial lavation
4.9
7.5
23
48
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
2.7
7.5
49
190
N03AX12
ATC
gabapentin; oral
2.2
7.4
79
390
61
HP
Catheterization and pressure measurement of the left side of the heart
7.8
7.4
16
21
7862A
ICD-9 Finland
Symptoms involving respiratory system and other chest symptoms, Cough
13.6
7.4
12
9
QA4S1
NOMESCO Finland
Photography of skin or subcutaneous tissue in face
13.6
7.4
12
9
C07AB07
ATC
bisoprolol; oral
1.7
7.4
210
1472
DHA10
NOMESCO Finland
Biopsy of cavity of nose
9.5
7.3
14
15
DLD10
NOMESCO Finland
Reconstruction of cartilage and bone of nose
+∞
7.3
7
*
Q34.0
ICD-10 Finland
Anomaly of pleura
+∞
7.3
7
*
GBB96
NOMESCO Finland
Other tracheostomy procedure
+∞
7.3
7
*
J41.0
ICD-10 Finland
Simple chronic bronchitis
16.0
7.2
11
7
R44
ICPC
Respiratory, Preventive immunization/medic
7.4
7.2
16
22
ZXA10
NOMESCO Finland
Bilateral
1.9
7.2
108
616
R01AD12
ATC
fluticasone furoate; nasal
1.7
7.2
162
1061
R07.4
ICD-10 Finland
Chest pain, unspecified
1.8
7.2
137
852
TDM10
NOMESCO Finland
Puncture of maxillary antrum
3.8
7.2
29
80
GDC01
NOMESCO Finland
Thoracoscopic lobectomy of lung
20.3
7.1
10
5
E27.3
ICD-10 Finland
Drug-induced adrenocortical insufficiency
20.3
7.1
10
5
Z50.8
ICD-10 Finland
Care involving use of other rehabilitation procedures
2.6
7.1
52
214
N02AX02
ATC
tramadol; systemic, rectal
1.7
7.1
205
1440
SPAT1262
SPAT
Handing over of treatment supplies
2.0
7.1
93
504
R5140
NOMESCO Finland
Monitoring the use of the aid
2.4
7.0
58
257
R95
ICPC
Chron obstructive pulmonary disease
4.9
6.9
21
44
A02BC03
ATC
lansoprazole; oral
1.8
6.9
139
879
FM1DE
NOMESCO Finland
Doppler ultrasound examination of heart
2.6
6.8
50
205
R09.3
ICD-10 Finland
Abnormal sputum
11.1
6.8
12
11
J10.1
ICD-10 Finland
Influenza with other respiratory manifestations, seasonal influenza virus identified
5.8
6.8
18
32
R4110
NOMESCO Finland
Physiotherapy
1.7
6.8
151
980
FM1AE
NOMESCO Finland
Standard cardiac ultrasound examination
2.0
6.8
83
438
R62.0
ICD-10 Finland
Delayed milestone
4.2
6.8
24
59
SPAT1253
SPAT
Initiation, adjustment, discontinuation or repetition of medication
1.7
6.7
166
1109
R03AL06
ATC
olodaterol and tiotropium bromide; inhalant
7.3
6.7
15
21
R49.08
ICD-10 Finland
Other specified dysphonia
5.3
6.7
19
37
C01DA14
ATC
isosorbide mononitrate; oral
2.2
6.7
65
310
WX722
NOMESCO Finland
PEEP
2.9
6.6
39
142
WYA30
NOMESCO Finland
Preparations for expected poor cooperation
2.5
6.6
52
222
SAA04
NOMESCO Finland
Special inverstigation of mouth
2.5
6.6
50
211
R5110
NOMESCO Finland
Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it
2.2
6.6
67
324
N05CF01
ATC
zopiclone; oral
1.7
6.6
154
1014
WX882
NOMESCO Finland
High dependency care
2.7
6.6
43
168
J01MA02
ATC
ciprofloxacin; systemic
1.7
6.5
180
1246
TDW99
NOMESCO Finland
Other minor procedure in surgery of ear, nose and larynx
3.6
6.5
27
77
A01AB09
ATC
miconazole; local oral
2.4
6.5
54
240
WZC30
NOMESCO Finland
Teaching
2.1
6.4
74
382
FM2CE
NOMESCO Finland
NA
3.7
6.4
26
73
J01EE02
ATC
sulfadiazine and trimethoprim; systemic
1.7
6.3
154
1023
R04
ICPC
Breathing problem other
3.4
6.3
28
84
201
Kela drug reimbursment
Chronic cardiac insufficiency
3.4
6.3
28
84
A06AD11
ATC
lactulose; oral
2.1
6.3
72
370
GCA98
NOMESCO Finland
Other bronchoscopic procedure on bronchus
9.4
6.3
12
13
S01CA01
ATC
dexamethasone and antiinfectives; ophthalmic (ophth., corticosteroids and antiinfectives in comb.)
1.7
6.3
158
1063
RK290
NOMESCO Finland
NA
18.2
6.3
9
5
D38.3
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Mediastinum
18.2
6.3
9
5
Q30.3
ICD-10 Finland
Congenital perforated nasal septum
+∞
6.3
6
*
J15.1
ICD-10 Finland
Pneumonia due to Pseudomonas
+∞
6.3
6
*
Q33.80
ICD-10 Finland
Congenital [cystic] adenomatoid malformation of lung
+∞
6.3
6
*
Q32.18
ICD-10 Finland
Other congenital malformations of trachea
+∞
6.3
6
*
DQW99
NOMESCO Finland
Other operation on larynx
+∞
6.3
6
*
R29
ICPC
Respiratory symptom/complaint other
2.6
6.3
42
167
J01DA01
ATC
[U] cefalexin; systemic
1.6
6.2
298
2361
J01FF01
ATC
clindamycin; systemic
1.7
6.1
129
822
UJF32
NOMESCO Finland
Coloscopy
1.8
6.1
120
750
B01AA03
ATC
warfarin; systemic
1.9
6.1
87
487
1240
FHL
Bronchoscopy
10.2
6.0
11
11
GAE10
NOMESCO Finland
Closure of previous incision of chest wall
10.2
6.0
11
11
XF400
NOMESCO Finland
ECG with 12 standard connections
1.8
6.0
102
606
205
Kela drug reimbursment
Chronic hypertension
1.7
6.0
124
786
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
149
381
4.86
55.48
2.0
1.4
122.74
211.26
u/ml
0.71
138
345
88
144
6.98
53.02
3.9
2.6
—
—
—
0
0
66
105
6.93
40.57
1.3
1.4
—
—
—
0
0
118
342
4.04
36.34
4.6
3.8
143.94
200.72
ng/l
1.10
108
314
37
47
8.32
27.53
1.6
1.5
2.00
0.07
u/ml
0.58
27
16
83
247
3.73
24.20
15.6
11.8
—
—
—
0
0
171
799
2.59
22.57
3.0
2.0
—
—
—
0
0
139
590
2.76
22.20
2.7
2.0
—
—
—
0
0
135
582
2.70
20.80
2.7
1.9
—
—
—
0
0
41
83
5.22
19.51
1.8
1.7
—
—
—
0
0
62
178
3.77
18.94
2.0
1.9
—
—
—
0
0
378
2612
2.19
18.84
9.9
7.6
28.25
30.93
%
4.42
364
2477
120
514
2.66
18.58
13.2
8.9
1.63
1.03
mmol/l
1.25
109
420
61
177
3.72
18.34
2.5
2.0
—
—
—
0
0
373
2580
2.16
18.33
9.7
7.4
56.99
54.00
%
4.60
358
2449
421
3055
2.24
18.29
11.8
10.6
4.25
3.88
e9/l
2.23
382
2613
110
457
2.72
18.06
3.7
3.6
9.39
9.43
g/l
0.03
105
427
29
51
5.92
16.00
4.1
3.6
—
—
—
0
0
352
2459
2.03
15.89
7.8
7.2
16.07
15.09
umol/l
0.22
339
2316
44
112
4.16
15.84
1.8
1.6
—
—
—
0
0
358
2519
2.03
15.80
15.8
9.1
1.22
1.22
mmol/l
0.42
316
2194
34
71
5.01
15.60
1.9
1.7
—
—
—
0
0
138
690
2.29
15.03
8.3
8.4
1.97
1.55
mmol/l
0.74
114
553
208
1232
2.05
14.65
5.3
3.7
1213.84
1292.47
ng/l
0.08
187
1039
300
2025
1.95
14.47
7.3
5.7
35.58
36.00
g/l
0.57
281
1907
33
72
4.79
14.39
2.2
4.3
—
—
—
0
0
29
58
5.20
13.96
1.2
1.1
—
—
—
0
0
33
74
4.66
13.93
2.2
4.1
12.70
8.55
%
1.05
23
60
387
2869
1.96
13.90
10.6
6.3
6.58
6.54
mmol/l
0.12
373
2688
226
1415
1.95
13.35
3.2
2.7
53.51
57.92
u/l
0.77
214
1309
159
881
2.09
13.22
6.1
4.0
199.27
401.22
ng/l
0.92
121
678
178
1068
1.94
11.64
3.1
2.6
1.32
1.23
mg/l
0.12
132
833
75
331
2.44
10.67
2.1
1.7
—
—
—
0
0
299
2160
1.76
10.43
5.4
4.1
—
—
—
0
0
318
2338
1.76
10.43
15.2
9.0
1.21
1.22
mmol/l
1.99
295
2154
25
57
4.53
10.35
2.7
2.7
105.64
105.30
mmol/l
0.12
25
57
29
75
4.01
10.23
1.9
3.8
643.68
509.89
e6/l
0.61
22
54
29
75
4.01
10.23
2.0
3.8
0.33
0.19
e9/l
1.16
22
55
25
58
4.45
10.13
2.7
2.7
3.94
4.03
mmol/l
0.50
25
58
13
16
8.28
9.76
3.8
7.3
—
—
—
0
0
36
112
3.35
9.73
1.3
1.8
—
—
—
0
0
441
3605
1.82
9.63
6.4
4.2
12.46
11.26
mm/h
0.96
425
3337
110
608
1.99
8.91
12.9
9.7
1.69
1.43
mmol/l
0.39
87
452
201
1344
1.74
8.87
2.6
2.2
174.24
222.04
u/l
0.65
187
1280
28
79
3.67
8.77
1.6
1.8
—
—
—
0
0
21
49
4.40
8.46
1.2
1.5
—
—
—
0
0
73
354
2.21
8.33
2.9
3.2
67.26
66.26
g/l
0.56
65
326
102
562
1.98
8.31
3.0
2.4
298.11
358.73
nmol/l
2.65
92
529
43
164
2.75
8.22
3.3
2.2
1.42
3.01
ug/l
0.44
37
153
21
52
4.15
7.86
2.0
1.3
—
—
—
0
0
27
83
3.36
7.46
1.3
1.4
—
—
—
0
0
36
134
2.79
7.22
1.7
1.9
—
—
—
0
0
240
1754
1.61
7.21
5.6
3.8
—
—
—
0
0
125
773
1.78
7.05
3.2
2.5
13.47
13.31
umol/l
0.09
116
715
431
3634
1.64
6.98
9.8
7.2
85.48
90.24
u/l
0.96
413
3419
222
1602
1.61
6.98
5.0
3.6
31.32
58.50
ng/l
0.58
149
1070
60
289
2.19
6.96
2.1
1.4
—
—
—
0
0
306
2390
1.57
6.80
5.5
3.8
0.00
0.01
estimate
0.50
45
415
10
6
16.92
6.76
4.1
1.5
34.50
42.17
umol/l
—
10
6
92
525
1.89
6.71
5.2
5.1
235.30
284.21
u/l
1.90
87
505
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
36
140
2.67
6.66
15.5
7.6
0.36
0.35
u/ml
0.13
19
83
33
123
2.78
6.61
10.0
8.7
203.00
329.45
iu/ml
—
8
20
42
180
2.43
6.38
1.2
1.3
—
—
—
0
0
270
2072
1.55
6.35
3.3
2.7
77.50
76.42
nmol/l
0.28
251
1873
28
98
2.95
6.28
1.8
1.7
—
—
—
0
0
79
438
1.92
6.28
6.9
5.2
75.86
69.25
ng/l
0.37
71
405
174
1214
1.61
6.16
2.7
2.4
3.03
3.01
mg/l
0.03
154
1049
298
2350
1.53
6.11
5.5
3.8
0.00
0.00
estimate
0.00
47
424
549
5012
2.01
6.05
30.7
16.3
139.63
139.62
mmol/l
0.03
542
4888
44
198
2.32
6.01
1.0
1.1
—
—
—
0
0
549
5024
1.98
5.82
31.0
16.4
3.98
3.97
mmol/l
0.02
542
4888
237
1796
1.52
5.76
5.2
3.6
—
—
—
0
0
134
890
1.65
5.74
1.8
1.7
58333905.82
15747429.07
pmol/l
0.32
108
743
297
2361
1.51
5.74
7.9
5.3
0.00
0.00
estimate
0.00
48
429
87
516
1.80
5.59
16.3
10.1
7.78
7.26
mmol/l
0.34
79
494
11
21
5.32
5.54
10.5
8.1
—
—
—
0
0
174
1243
1.56
5.48
4.5
4.0
9.65
23.10
mg/mmol
0.44
112
783
545
4994
1.91
5.48
28.3
13.8
22.05
22.56
mg/l
0.15
494
3829
115
746
1.67
5.37
1.8
1.7
976.69
1203.43
nmol/l
2.73
89
555
110
710
1.67
5.23
3.4
2.5
2.37
2.42
g/l
0.34
102
659
105
671
1.68
5.19
3.4
2.6
22.77
22.29
%
0.11
85
591
413
3554
1.51
5.16
3.8
3.3
—
—
—
0
0
491
4398
1.61
5.03
29.9
17.6
13.72
13.57
%
1.52
485
4330
151
1066
1.55
4.95
5.2
3.9
1.02
1.02
kg/l
0.83
30
169
121
811
1.61
4.95
9.6
6.4
0.83
0.81
mmol/l
0.82
113
769
26
102
2.62
4.77
3.3
3.2
16.70
16.59
%
0.04
21
58
208
1583
1.48
4.75
5.5
3.7
17.31
98.14
e6/l
1.18
163
1189
366
3107
1.45
4.65
4.4
3.5
43.58
45.39
u/l
0.23
354
2934
33
147
2.32
4.65
1.3
1.5
—
—
—
0
0
189
1418
1.48
4.62
3.9
3.6
6.82
7.52
mmol/l
1.33
164
1213
30
130
2.38
4.50
1.9
1.3
—
—
—
0
0
30
130
2.38
4.50
1.9
1.3
—
—
—
0
0
271
2186
1.43
4.50
3.5
2.9
104.71
107.75
ug/l
0.11
259
2035
21
76
2.83
4.49
10.9
6.6
9.59
11.10
mg/l
0.63
21
70
82
513
1.69
4.37
8.6
8.8
24.40
23.83
mmol/l
1.29
75
484
26
107
2.49
4.36
1.7
1.9
—
—
—
0
0
119
820
1.56
4.30
14.1
8.0
1.18
1.19
mmol/l
0.14
111
767
517
4737
1.62
4.28
29.3
15.7
37.95
39.68
%
2.80
340
3689
491
4461
1.53
4.06
5.8
4.6
1.95
2.20
mu/l
0.44
467
4115
27
119
2.33
3.93
1.0
1.1
—
—
—
0
0
163
1227
1.45
3.82
2.0
1.8
1.34
1.41
mmol/l
0.49
142
1055
426
3785
1.42
3.78
5.0
3.8
14.78
14.71
pmol/l
0.21
404
3453
188
1456
1.42
3.77
4.9
3.5
0.17
0.39
e6/l
2.56
147
1057
16
55
2.96
3.76
1.2
1.7
—
—
—
0
0
89
596
1.58
3.63
5.2
4.4
6.08
7.88
umol/l
0.69
79
519
217
1734
1.39
3.60
2.1
1.9
97.59
97.25
pmol/l
0.03
109
893
154
1162
1.44
3.53
3.6
2.6
—
—
—
0
0
58
353
1.71
3.44
4.3
4.0
1.25
1.23
mmol/l
0.58
50
309
151
1142
1.43
3.41
3.8
3.3
9869.72
5329.69
umol/l
0.37
132
993
120
872
1.47
3.35
4.3
3.4
4.28
2.35
e6/l
0.78
75
450
25
115
2.22
3.33
2.1
1.5
—
—
—
0
0
157
1203
1.41
3.29
1.8
1.7
—
—
—
0
0
549
5173
1.65
3.25
14.4
10.4
25.31
26.21
u/l
0.80
533
4994
123
906
1.45
3.19
3.6
3.1
0.91
0.88
e6/l
0.07
75
477
30
152
2.02
3.15
2.3
2.1
—
—
—
0
0
30
152
2.02
3.15
2.3
2.1
7.98
7.41
g/l
0.79
19
117
30
152
2.02
3.15
2.3
2.1
3.78
3.72
g/l
0.09
17
111
11
34
3.28
3.07
6.5
2.4
—
—
—
0
0
7
12
5.89
3.02
3.3
3.1
—
—
—
0
0
165
1292
1.38
3.02
1.7
1.6
2.03
2.11
g/l
0.27
115
731
49
296
1.71
3.01
2.4
1.7
—
—
—
0
0
55
345
1.65
2.94
2.7
2.3
4.66
6.83
ug/l
1.08
46
304
10
31
3.26
2.78
1.3
1.7
—
—
—
0
0
11
38
2.93
2.59
1.2
1.3
36205.17
68715.26
e6/l
—
6
19
473
4380
1.36
2.56
5.1
4.2
5.81
5.86
mmol/l
0.40
441
3997
12
44
2.76
2.56
1.2
1.7
—
—
—
0
0
42
256
1.69
2.53
1.6
1.8
35.20
22.23
iu/l
1.36
35
202
106
794
1.41
2.50
1.3
1.3
48.08
33.10
iu/ml
0.21
29
249
9
26
3.50
2.49
1.1
1.2
—
—
—
0
0
9
26
3.50
2.49
1.1
1.2
84.44
80.88
%
—
9
26
8
21
3.84
2.47
2.6
1.9
—
—
—
0
0
8
21
3.84
2.47
2.6
1.9
—
—
—
0
0
154
1228
1.34
2.46
5.8
4.0
0.00
0.00
estimate
0.50
44
419
134
1047
1.36
2.45
1.6
1.5
22.71
21.54
nmol/l
0.32
116
892
8
22
3.67
2.37
2.6
1.8
—
—
—
0
0
22
112
2.00
2.33
2.8
4.7
34.72
53.74
mg/l
0.28
16
89
22
112
2.00
2.33
2.9
4.7
25.89
107.32
mg/l
0.81
16
90
65
450
1.50
2.32
5.2
3.3
—
—
—
0
0
9
28
3.25
2.31
2.4
1.7
—
—
—
0
0
9
28
3.25
2.31
2.4
1.7
—
—
—
0
0
9
28
3.25
2.31
2.4
1.7
—
—
—
0
0
9
28
3.25
2.31
2.4
1.7
—
—
—
0
0
474
4414
1.34
2.29
4.8
4.2
1.43
1.48
mmol/l
1.74
439
4088
134
1059
1.34
2.27
4.8
2.9
4.50
6.18
e6/l
0.90
116
933
26
142
1.87
2.26
3.0
1.9
100.00
91.59
u/ml
—
5
18
26
142
1.87
2.26
2.4
2.1
2.84
3.12
g/l
0.60
18
113
5
9
5.59
2.21
2.0
3.8
—
—
—
0
0
30
174
1.76
2.17
1.7
2.0
—
—
—
0
0
9
30
3.03
2.15
1.0
1.2
—
—
—
0
0
18
88
2.08
2.13
5.1
4.1
50.56
55.89
%
0.68
18
88
476
4451
1.32
2.12
4.9
4.3
4.56
4.68
mmol/l
1.75
446
4141
458
4264
1.30
2.08
4.3
3.9
1.25
1.28
mmol/l
0.40
426
3939
190
1593
1.28
2.08
3.6
3.3
2.34
2.36
mmol/l
1.57
168
1404
27
154
1.79
2.07
2.2
1.8
292.30
206.35
u/ml
0.30
15
76
578
5598
1.70
2.04
36.2
20.4
263.26
256.81
e9/l
1.49
565
5406
6
15
4.03
2.04
5.2
8.5
—
—
—
0
0
26
148
1.79
2.01
3.1
1.8
—
—
—
0
0
578
5603
1.68
1.96
36.2
20.3
4.50
4.51
e12/l
0.17
566
5400
6
16
3.78
1.94
1.2
1.3
—
—
—
0
0
27
158
1.74
1.92
2.3
1.8
—
—
—
0
0
13
58
2.27
1.92
1.8
2.8
16.12
20.09
ug/l
0.74
13
58
578
5606
1.67
1.92
36.9
20.6
133.71
134.43
g/l
0.59
573
5531
29
174
1.70
1.89
3.8
1.9
—
—
—
0
0
12
52
2.33
1.88
2.1
1.6
—
—
—
0
0
12
52
2.33
1.88
2.1
1.6
—
—
—
0
0
12
52
2.33
1.88
2.1
1.6
—
—
—
0
0
17
86
2.00
1.86
4.1
3.6
4.25
4.14
e9/l
0.06
17
86
98
769
1.33
1.74
1.2
1.3
22.08
11.41
u/ml
0.49
38
300
16
82
1.98
1.71
4.5
3.2
13.51
23.79
mu/l
0.51
16
77
12
55
2.21
1.68
6.6
4.3
78.83
93.78
%
1.58
12
55
6
19
3.18
1.66
1.5
1.2
—
—
—
0
0
6
20
3.02
1.58
1.2
1.1
—
—
—
0
0
7
26
2.71
1.58
1.4
1.7
—
—
—
0
0
476
4506
1.26
1.57
5.3
4.7
2.68
2.78
mmol/l
1.61
435
4160
19
108
1.78
1.52
1.2
1.1
1.05
8.67
u/ml
2.78
13
55
7
27
2.61
1.52
1.4
1.7
—
—
—
0
0
13
65
2.02
1.49
1.2
1.2
—
—
—
0
0
26
163
1.62
1.48
3.4
1.7
—
—
—
0
0
46
328
1.44
1.48
3.5
2.4
13.63
12.93
nmol/l
0.22
41
282
17
95
1.81
1.44
1.4
1.4
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
11
53
2.10
1.39
1.0
1.3
—
—
—
0
0
12
60
2.02
1.39
2.0
2.8
31.83
31.97
pg
0.04
12
60
12
60
2.02
1.39
1.2
1.4
—
—
—
0
0
5
17
2.96
1.36
3.8
4.7
—
—
—
0
0
48
351
1.40
1.36
1.2
1.3
86.19
167.38
iu/ml
1.53
17
139
20
120
1.69
1.35
1.2
1.1
5.36
8.98
u/ml
0.38
13
61
27
177
1.55
1.31
1.6
2.1
7.15
8.19
u/l
0.21
21
131
24
153
1.59
1.30
1.3
3.5
65.83
5.80
e6/l
0.61
18
111
24
153
1.59
1.30
1.4
3.6
2163.32
1201.65
e6/l
0.18
19
113
68
531
1.32
1.28
27.7
21.3
1.30
1.23
inr
—
10
74
22
138
1.62
1.28
1.1
1.1
—
18.15
—
0
6
29
195
1.51
1.26
1.2
1.2
3.32
2.73
u/ml
0.09
16
116
15
85
1.78
1.24
1.5
1.2
—
—
—
0
0
19
117
1.64
1.19
1.3
1.1
—
—
—
0
0
29
412
0.69
1.16
2.1
1.7
—
—
—
0
0
8
39
2.06
1.15
1.3
1.7
128.39
141.76
ng/l
—
8
33
46
348
1.35
1.09
2.7
3.1
64.89
68.47
ml/min/173m2
0.20
18
143
(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay
5
21
2.39
1.09
1.0
1.4
103.00
109.95
%
—
5
21
5
21
2.39
1.09
4.8
5.7
—
—
—
0
0
5
21
2.39
1.09
4.4
5.7
—
—
—
0
0
18
113
1.61
1.06
1.3
1.2
—
10.55
—
0
8
22
146
1.53
1.04
1.3
1.2
—
—
—
0
0
433
4121
1.18
1.04
7.1
5.5
39.85
39.42
mmol/mol
0.44
402
3853
5
22
2.28
1.03
2.2
1.9
—
—
—
0
0
24
164
1.48
1.00
1.5
3.3
740.83
442.87
mg/l
0.37
24
158
25
354
0.69
1.00
1.0
1.1
—
—
—
0
0
9
49
1.85
0.99
1.0
1.3
—
—
—
0
0
5
23
2.18
0.98
1.0
1.2
—
—
—
0
0
0
29
0.00
0.98
0.0
1.2
—
4.59
—
0
24
22
150
1.48
0.94
1.3
1.4
—
—
—
0
0
47
594
0.77
0.92
2.3
2.8
0.66
0.72
ug/l
0.18
30
375
23
160
1.45
0.90
1.7
1.4
297.94
305.21
ug/g
0.07
16
90
8
43
1.87
0.87
2.3
1.2
—
—
—
0
0
55
443
1.27
0.87
2.9
4.2
11.81
17.80
ug/l
0.21
45
367
21
145
1.46
0.86
1.2
1.2
15.40
6.91
u/ml
—
6
23
8
45
1.79
0.84
1.1
1.4
—
—
—
0
0
57
464
1.25
0.83
2.7
2.6
28.24
34.65
u/l
0.88
50
388
24
173
1.40
0.80
2.0
2.4
21919.71
2997.95
u/l
—
8
62
15
98
1.54
0.79
5.3
4.1
30.87
27.24
mg/l
—
9
68
19
132
1.45
0.76
2.7
1.8
42.00
36.69
nmol/l
0.52
19
127
6
34
1.77
0.76
1.2
1.0
—
—
—
0
0
26
192
1.37
0.76
1.7
1.8
—
—
—
0
0
24
175
1.39
0.75
1.2
1.2
3.04
4.19
u/ml
—
10
53
18
125
1.45
0.73
2.4
1.7
—
—
—
0
0
7
43
1.63
0.67
1.1
1.1
—
—
—
0
0
5
28
1.79
0.66
2.2
1.3
—
—
—
0
0
5
28
1.79
0.66
1.2
1.1
—
—
—
0
0
5
28
1.79
0.66
2.2
1.3
—
—
—
0
0
11
70
1.58
0.65
2.9
1.7
—
—
—
0
0
7
44
1.60
0.65
1.1
1.1
—
—
—
0
0
17
120
1.43
0.65
3.1
2.0
0.00
0.04
g/l
0.50
17
112
14
95
1.48
0.64
1.7
1.6
—
—
—
0
0
5
29
1.73
0.64
8.8
5.3
—
—
—
0
0
8
49
1.64
0.62
1.1
1.1
—
—
—
0
0
8
49
1.64
0.62
1.1
1.1
—
—
—
0
0
8
50
1.61
0.61
1.1
1.1
—
—
—
0
0
8
50
1.61
0.61
1.1
1.1
—
—
—
0
0
8
50
1.61
0.61
1.1
1.1
—
—
—
0
0
0
20
0.00
0.60
0.0
1.0
—
3.14
—
0
10
15
105
1.44
0.60
1.1
1.1
0.03
0.86
u/ml
—
5
40
0
21
0.00
0.60
0.0
1.1
—
359.14
—
0
14
0
21
0.00
0.60
0.0
1.3
—
—
—
0
0
0
22
0.00
0.59
0.0
1.2
—
—
—
0
0
16
114
1.41
0.59
1.4
1.2
—
—
—
0
0
15
106
1.43
0.58
1.5
1.4
—
—
—
0
0
44
525
0.83
0.57
5.0
4.3
36.41
31.93
%
1.57
29
351
6
36
1.67
0.57
3.5
1.7
—
—
—
0
0
6
38
1.58
0.54
1.3
1.0
—
—
—
0
0
9
61
1.48
0.54
1.2
1.0
—
—
—
0
0
31
250
1.25
0.53
4.4
2.8
20.04
53.57
u/ml
1.58
31
241
12
83
1.45
0.52
1.4
1.1
—
—
—
0
0
9
65
1.39
0.50
1.1
1.1
—
—
—
0
0
23
180
1.29
0.50
1.2
1.2
4.06
7.04
u/ml
0.55
13
125
10
67
1.50
0.50
1.1
1.1
—
—
—
0
0
20
156
1.29
0.45
1.2
2.0
—
—
—
0
0
51
585
0.86
0.45
3.2
2.3
—
—
—
0
0
58
510
1.15
0.43
8.2
6.4
—
—
—
0
0
8
56
1.43
0.42
3.0
3.6
20.50
28.29
umol/l
—
8
56
110
1011
1.11
0.41
4.6
4.6
5.16
2.21
ug/l
0.39
101
912
0
15
0.00
0.41
0.0
1.0
—
2.69
—
0
6
36
306
1.19
0.40
1.1
1.1
—
0.88
—
0
5
8
60
1.34
0.40
1.0
1.0
—
—
—
0
0
12
160
0.74
0.40
2.1
1.4
—
—
—
0
0
13
97
1.35
0.39
2.1
2.5
73.94
74.16
ug/min
—
8
53
0
19
0.00
0.39
0.0
1.0
—
21.96
—
0
9
23
188
1.23
0.38
1.8
1.6
—
—
—
0
0
148
1390
1.09
0.36
1.4
1.5
1.22
1.77
u/ml
0.57
35
330
6
44
1.37
0.34
1.2
1.5
—
—
—
0
0
6
45
1.34
0.34
1.5
1.1
—
94.40
—
0
5
6
46
1.31
0.33
1.8
1.7
—
—
—
0
0
19
156
1.22
0.31
6.6
4.6
2.07
1.36
mmol/l
0.69
19
150
10
75
1.34
0.30
1.1
1.1
—
—
—
0
0
14
112
1.26
0.28
3.5
2.0
0.00
0.00
g/l
0.00
14
105
14
112
1.26
0.28
3.5
2.0
0.00
0.00
g/l
0.00
14
105
21
177
1.19
0.28
2.0
3.0
5742.80
911.68
u/ml
0.38
15
151
29
255
1.14
0.24
2.7
2.0
—
—
—
0
0
18
152
1.19
0.24
2.4
1.4
—
—
—
0
0
5
39
1.28
0.23
1.4
1.2
45.00
87.10
u/l
—
5
29
5
39
1.28
0.23
4.4
4.2
—
—
—
0
0
35
315
1.12
0.22
3.2
2.1
—
—
—
0
0
0
14
0.00
0.20
0.0
1.0
—
22.31
—
0
14
0
14
0.00
0.20
0.0
1.4
—
—
—
0
0
0
14
0.00
0.20
0.0
1.0
—
12.12
—
0
7
6
51
1.18
0.19
1.3
1.5
—
—
—
0
0
75
710
1.06
0.17
1.6
1.4
—
—
—
0
0
5
69
0.72
0.17
1.4
1.5
0.15
0.27
nmol/l
—
5
53
84
803
1.05
0.14
5.3
4.1
20.63
21.41
%
0.17
38
343
19
170
1.12
0.13
1.3
1.4
162.86
262.79
miu/ml
—
7
78
415
4194
0.97
0.13
19.8
12.3
84.69
83.85
ml/min/173m2
0.29
339
3372
12
138
0.87
0.13
1.5
1.4
—
—
—
0
0
12
137
0.87
0.12
1.3
1.3
—
—
—
0
0
52
542
0.96
0.09
3.0
2.1
—
—
—
0
0
28
296
0.94
0.07
1.3
1.2
—
—
—
0
0
7
80
0.87
0.07
2.6
1.4
—
—
—
0
0
7
80
0.87
0.07
2.6
1.4
—
—
—
0
0
7
80
0.87
0.07
2.6
1.4
—
—
—
0
0
7
83
0.84
0.07
2.0
4.2
8.90
3316.03
u/ml
—
7
78
8
90
0.89
0.07
2.9
4.6
473.00
394.62
umol/l
—
8
85
8
94
0.85
0.06
2.4
1.5
—
—
—
0
0
17
158
1.08
0.06
1.3
1.1
—
—
—
0
0
13
120
1.08
0.05
2.2
1.8
3.07
5.51
iu/l
—
7
41
17
162
1.05
0.02
1.3
1.1
—
—
—
0
0
80
791
1.01
0.01
2.9
2.8
2.44
2.45
mmol/l
0.28
65
698
0
7
0.00
0.00
0.0
3.9
—
55.46
—
0
7
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
5
58
0.86
0.00
1.2
1.4
—
—
—
0
0
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
0
6
0.00
0.00
0.0
2.2
—
15.40
—
0
6
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
Mortality – FinRegistry
↥Association
Association between endpoint Q17_CONGEN_MALFO_RESPI_SYSTEM and mortality.
Females
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| Q17_CONGEN_MALFO_RESPI_SYSTEM | 1.645 [1.4, 1.93] | < 0.001 |
| Birth year | 0.998 [0.99, 1.01] | 0.609 |
During the follow-up period (1.1.1998 — 31.12.2019), 351 out of 2898 females with Q17_CONGEN_MALFO_RESPI_SYSTEM died.
Males
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| Q17_CONGEN_MALFO_RESPI_SYSTEM | 1.793 [1.51, 2.13] | < 0.001 |
| Birth year | 0.989 [0.98, 1.0] | 0.048 |
During the follow-up period (1.1.1998 — 31.12.2019), 306 out of 3120 males with Q17_CONGEN_MALFO_RESPI_SYSTEM died.
Mortality risk
Mortality risk for people of age
years, who have Q17_CONGEN_MALFO_RESPI_SYSTEM.| N-year risk | Females | Males |
|---|---|---|
| 1 | 0.152% | 0.304% |
| 5 | 0.981% | 2.075% |
| 10 | 2.571% | 5.326% |
| 15 | 4.954% | 10.257% |
| 20 | 8.949% | 16.892% |
Relationships between endpoints
↥Index endpoint: Q17_CONGEN_MALFO_RESPI_SYSTEM – Congenital malformations of the respiratory system
GWS hits: -
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
rg [CI]
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data